Header Logo

Connection

JAMES WELSH to Radiotherapy Dosage

Back to Details
This is a "connection" page, showing publications JAMES WELSH has written about Radiotherapy Dosage.
JAMES WELSH
Connection Strength
1.699
Radiotherapy Dosage
  1. In Regard to Shuryak et al. Int J Radiat Oncol Biol Phys. 2021 10 01; 111(2):574-576.
    View in: PubMed
    Score: 0.435
  2. In Regard to Papachristofilou et al. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1550-1551.
    View in: PubMed
    Score: 0.106
  3. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol. 2019 11 01; 5(11):1597-1604.
    View in: PubMed
    Score: 0.095
  4. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol. 2017 02; 12(2):375-382.
    View in: PubMed
    Score: 0.077
  5. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1084-1091.
    View in: PubMed
    Score: 0.066
  6. Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol. 2013 Mar; 106(3):327-32.
    View in: PubMed
    Score: 0.060
  7. Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):e231-9.
    View in: PubMed
    Score: 0.056
  8. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e391-8.
    View in: PubMed
    Score: 0.056
  9. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1336-42.
    View in: PubMed
    Score: 0.053
  10. A planning study for palliative spine treatment using StatRT and megavoltage CT simulation. J Appl Clin Med Phys. 2010 Oct 30; 12(1):3348.
    View in: PubMed
    Score: 0.051
  11. Surface applicator calibration and commissioning of an electronic brachytherapy system for nonmelanoma skin cancer treatment. Med Phys. 2010 Oct; 37(10):5509-17.
    View in: PubMed
    Score: 0.051
  12. Clinical, technical, and basic science progress in helical tomotherapy--the pace continues to accelerate. Technol Cancer Res Treat. 2009 Feb; 8(1):1-2.
    View in: PubMed
    Score: 0.045
  13. Multimodality image guided total marrow irradiation and verification of the dose delivered to the lung, PTV, and thoracic bone in a patient: a case study. Technol Cancer Res Treat. 2009 Feb; 8(1):23-8.
    View in: PubMed
    Score: 0.045
  14. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):159-65.
    View in: PubMed
    Score: 0.040
  15. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat. 2006 Oct; 5(5):465-79.
    View in: PubMed
    Score: 0.038
  16. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2006; 66(2 Suppl):S62-73.
    View in: PubMed
    Score: 0.036
  17. Helical tomotherapy as a means of delivering scalp-sparing whole brain radiation therapy. Technol Cancer Res Treat. 2005 Dec; 4(6):661-2; author reply 662.
    View in: PubMed
    Score: 0.036
  18. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy. Technol Cancer Res Treat. 2004 Aug; 3(4):359-64.
    View in: PubMed
    Score: 0.033
  19. Dose rate in external beam radiotherapy for prostate cancer: an overlooked confounding variable? Urology. 2003 Aug; 62(2):204-6.
    View in: PubMed
    Score: 0.031
  20. Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants. Arch Toxicol. 2021 10; 95(10):3425-3432.
    View in: PubMed
    Score: 0.027
  21. Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. Clin Cancer Res. 2020 09 01; 26(17):4643-4650.
    View in: PubMed
    Score: 0.025
  22. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis. Clin Lung Cancer. 2018 11; 19(6):e885-e891.
    View in: PubMed
    Score: 0.022
  23. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2017 09 01; 99(1):128-135.
    View in: PubMed
    Score: 0.020
  24. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):141-148.
    View in: PubMed
    Score: 0.019
  25. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Pract Radiat Oncol. 2017 May - Jun; 7(3):e195-e203.
    View in: PubMed
    Score: 0.019
  26. Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):63-71.
    View in: PubMed
    Score: 0.019
  27. Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation. Clin Lung Cancer. 2015 Mar; 16(2):156-63.
    View in: PubMed
    Score: 0.017
  28. Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):139-47.
    View in: PubMed
    Score: 0.016
  29. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol. 2012 Sep 10; 7:152.
    View in: PubMed
    Score: 0.015
  30. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases. PLoS One. 2012; 7(4):e35809.
    View in: PubMed
    Score: 0.014
  31. Postmastectomy radiotherapy with integrated scar boost using helical tomotherapy. Med Dosim. 2012; 37(3):233-9.
    View in: PubMed
    Score: 0.014
  32. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non?small-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):856-62.
    View in: PubMed
    Score: 0.013
  33. Helical tomotherapy versus single-arc intensity-modulated arc therapy: a collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):284-96.
    View in: PubMed
    Score: 0.013
  34. Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dosim. 2011; 36(4):383-8.
    View in: PubMed
    Score: 0.013
  35. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat. 2009 Mar; 114(2):307-13.
    View in: PubMed
    Score: 0.011
  36. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71.
    View in: PubMed
    Score: 0.008
  37. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):455-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.